Many researchers are interested in utilizing state-of-the-art technologies such as microarray-based transcriptomic and genomic analyses to attempt to dissect molecular profiles. Within the past decade we have witnessed significant advancements in research that are directly associated with the output of the genome sequencing endeavor. The results of these achievements provide hope to investigators researching complex diseases like cancer. Alterations in genes causing these diseases may result in one or several genes having aberrant genomic profiles or even hundreds to thousands of genes with perturbed function. This can result in a mishmash of genomic profiles that is difficult to sort through, presenting a challenge to researchers attempting to elucidate the cause and effect of cancer. To assist BCMCC investigators with these issues, the Genomic Profiling Resource will integrate two existing Baylor College of Medicine (BCM) facilities to provide state-of-the-art access to transcriptional or genomic profiling using microarray technology. The Resource utilizes spotted glass microarrays and the commercially available Affymetrix GeneChip? platform and offers expert advice in experimental design, data analysis, and bioinformatics, as well as access to computing hardware and software. Services offered by the Resource include sample quality control, expression profiling with microarrays, quantitative (real time) PCR, access to a cDNA clone respository, comparative genomic hybridization on spotted arrays, SNP genotyping utilizing Affymetrix GeneChips, data analysis, training, and workshops. Led by Drs. Lisa White and Ching Lau, this Core will provide a cost-effective resource for Cancer Center researchers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-03
Application #
7900429
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$131,453
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Guarducci, Cristina; Bonechi, Martina; Benelli, Matteo et al. (2018) Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer. NPJ Breast Cancer 4:38
Byrd, Tiara T; Fousek, Kristen; Pignata, Antonella et al. (2018) TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer. Cancer Res 78:489-500
Xing, Zhen; Zhang, Yanyan; Liang, Ke et al. (2018) Expression of Long Noncoding RNA YIYA Promotes Glycolysis in Breast Cancer. Cancer Res 78:4524-4532
Creighton, Chad J (2018) The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther 18:973-980
Szwarc, Maria M; Hai, Lan; Gibbons, William E et al. (2018) Retinoid signaling controlled by SRC-2 in decidualization revealed by transcriptomics Reproduction 156:387-395
Nguyen, Tuan M; Kabotyanski, Elena B; Dou, Yongchao et al. (2018) FGFR1-Activated Translation of WNT Pathway Components with Structured 5' UTRs Is Vulnerable to Inhibition of EIF4A-Dependent Translation Initiation. Cancer Res 78:4229-4240
Kho, Jordan; Tian, Xiaoyu; Wong, Wing-Tak et al. (2018) Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension. Am J Hum Genet 103:276-287
Chiang, Angie C A; Fowler, Stephanie W; Savjani, Ricky R et al. (2018) Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med 215:1349-1364
Zhang, Yan; Zheng, Dayong; Zhou, Ting et al. (2018) Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers. Nat Commun 9:4080
Grzeskowiak, Caitlin L; Kundu, Samrat T; Mo, Xiulei et al. (2018) In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat Commun 9:2732

Showing the most recent 10 out of 991 publications